Cytek Biosciences Inc (CTKB)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for Cytek Biosciences Inc has been consistently marked as "— days" in the financial data provided from December 31, 2020, to December 31, 2024. This indicates that detailed information on accounts receivable turnover and the time taken to collect sales revenue is not available in the dataset. In order to perform a comprehensive analysis of the DSO ratio for Cytek Biosciences Inc, it would be necessary to acquire the specific accounts receivable and sales data corresponding to each period mentioned in the dataset. Analyzing the DSO ratio can provide valuable insights into the company's efficiency in collecting outstanding sales and managing its accounts receivable, which are crucial aspects of its financial health and operational performance.
Peer comparison
Dec 31, 2024